CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

Item

http://www.wikidata.org/entity/Q34692141

Q34692141

about

The evolution of poxvirus vaccines Sang Froid in a time of trouble: is a vaccine against HIV possible?Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans Memories that last forever: strategies for optimizing vaccine T-cell memory.DNA/MVA Vaccines for HIV/AIDS Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes.Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.HIV DNA Vaccine: Stepwise Improvements Make a Difference.Enhancing poxvirus vectors vaccine immunogenicity.CTL quality and the control of human retroviral infections.Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.Costimulation signals for memory CD8+ T cells during viral infections.Modulation of HIV-1 immunity by adjuvants.Human immunodeficiency virus-1 vaccine design: where do we go now?Innate immune recognition of poxviral vaccine vectors.Development of targeted adjuvants for HIV-1 vaccines Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity.Adjuvant effect of CD40 on H5N1 DNA vaccine in mice.A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys.

P2860

Q26995905-8802ADDC-D3D2-42E2-BB7D-3286E5938908 Q27487961-4F3986ED-5250-4B46-B841-54F1DEFEBE24 Q27497985-CDBE54FE-16CD-405D-B9D0-9B3FD84D904F Q28741103-A522BE9A-A843-4B76-AFA2-4D5898A4FDFF Q34060493-875F8725-B846-4E74-B430-CB8196376B1D Q34492802-4FF0DDE1-70A8-414E-89DC-FC875BAEA051 Q34511092-5EBDBE05-B944-4561-8477-574AEEFE9666 Q34727759-83841062-0601-49F2-8C53-96DF15E354C5 Q35075505-7AD71CFA-FEF8-44F3-B84D-9BB7C8AFB3A6 Q35096745-297B1443-618D-4709-AFDF-EFD0525D7362 Q35108680-E48BEF51-5BFB-48D2-A627-4516AF2AFDC8 Q35661163-D913AE13-09E3-42F0-874D-E254468FEEBC Q35826742-05CAA1DB-2F17-4982-AA2C-3B93CE7CB614 Q36978452-B215DBA2-E994-4458-8AA6-D1F003008ACF Q37543246-F0A55587-7AE6-4BA0-9EAC-91F70FC31C9A Q37590335-508C2EFB-E811-4895-A09D-EB4C7C51DD62 Q37668114-C65D0641-E592-4AFA-BF76-07E02F183BA3 Q37685171-597EFE14-1686-434B-A853-3C2D07B13DED Q37698564-106946D4-B6B8-4428-880D-F2E5ED5A329A Q37801269-54BC293E-58FC-4E92-B685-0B7E51607C42 Q37944321-5E8979AD-8D25-4B96-9D39-684F98D5D138 Q41277922-5E6827A6-4F84-4803-9DC9-0D16F6BA3750 Q41822355-1FFEF769-BB22-4B2A-BDA3-20D55D2C5437 Q42247942-1848DDF3-471D-4AF6-BB04-6A79FCF47F57 Q42837168-4872044D-5E3C-4326-B76E-6AEE56123436 Q45888470-8304FB4C-B57E-4500-BD0C-3031A7DCBC53

P2860

CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

Item

http://www.wikidata.org/entity/Q34692141

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu